Loading stock data...

Sunil Healthcare Limited

BSE: SUNLOC

BSE
67.00 -1.95 (-2.83%)

Prev Close

68.95

Open Price

70

Volume

3

Today Low / High

67 / 70

52 WK Low / High

60.55 / 88.7

Range

64 - 70

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 67, reflecting a change of -1.95 (-2.82814%). The expected target range on the BSE is 64 - 70. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

25 Feb 70.00 -4.29%
23 Feb 69.00 -0.07%
20 Feb 70.00 -1.43%
19 Feb 70.00 -3.96%
18 Feb 66.00 -0.44%
17 Feb 70.00 -2.86%
16 Feb 69.00 -5.00%
13 Feb 70.38 -3.38%
12 Feb 69.65 -0.93%
11 Feb 69.00 1.45%
10 Feb 67.78 3.26%
09 Feb 72.00 -5.86%
06 Feb 69.55 0.09%
05 Feb 70.00 -0.64%
04 Feb 70.00 -2.29%
03 Feb 68.44 -3.43%
02 Feb 70.00 -2.23%
01 Feb 65.00 -1.35%
30 Jan 70.00 -7.14%
29 Jan 69.00 -0.39%
28 Jan 66.00 3.79%

Sunil Healthcare Limited Graph

Sunil Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Sunil Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 67.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 67.00 67.67 60.90 - 74.44
68.34 54.67 - 82.01
69.01 48.31 - 89.71
Bearish Scenario 67.00 66.33 59.70 - 72.96
65.66 52.53 - 78.79
64.99 45.49 - 84.49

Overview of Sunil Healthcare Limited

ISIN

INE671C01016

Industry

Medical - Pharmaceuticals

Vol.Avg

622

Market Cap

687,068,250

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

171.18

DCF

-84

Financial Ratios Every Investor Needs

Stock Rating Details for SUNLOC

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 83.42 Cr 54.82 Cr 28.60 Cr 0.3429 0.00 Cr 1.26 Cr 3.91 Cr -1.42 Cr -1.39 11.60 Cr -0.0170
2024-03-31 90.16 Cr 82.66 Cr 41.56 Cr 0.4610 0.00 Cr 1.66 Cr -1.72 Cr -1.79 Cr -1.74 9.31 Cr -0.0198
2023-03-31 110.46 Cr 51.10 Cr 59.36 Cr 0.5374 0.00 Cr 2.41 Cr 12.24 Cr 6.68 Cr 6.52 20.66 Cr 0.0605
2022-03-31 119.16 Cr 53.11 Cr 66.05 Cr 0.5543 0.00 Cr 2.39 Cr 16.46 Cr 6.42 Cr 6.26 18.13 Cr 0.0539
2021-03-31 90.33 Cr 46.54 Cr 43.79 Cr 0.4848 0.00 Cr 2.00 Cr 4.66 Cr -0.64 Cr -0.62 10.06 Cr -0.0071

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.03 Cr 161.94 Cr 94.88 Cr 67.0662 Cr 68.64 Cr 65.56 Cr 17.64 Cr 94.13 Cr 0.00 Cr 0.00 Cr 1.50 Cr 62.6018 Cr
2024-03-31 0.08 Cr 158.50 Cr 90.28 Cr 68.2168 Cr 66.15 Cr 66.07 Cr 14.05 Cr 93.22 Cr 0.60 Cr 0.00 Cr -1.40 Cr 57.3006 Cr
2023-03-31 0.59 Cr 120.79 Cr 64.79 Cr 55.9969 Cr 36.79 Cr 36.20 Cr 13.60 Cr 70.38 Cr 0.11 Cr 0.00 Cr 2.27 Cr 45.4846 Cr
2022-03-31 0.27 Cr 109.69 Cr 59.74 Cr 49.9549 Cr 34.68 Cr 34.42 Cr 11.05 Cr 71.55 Cr 4.28 Cr 0.00 Cr 1.03 Cr 39.8115 Cr
2021-03-31 0.55 Cr 120.56 Cr 76.85 Cr 43.7173 Cr 49.82 Cr 49.27 Cr 13.73 Cr 69.61 Cr 3.87 Cr 0.00 Cr 1.07 Cr 53.5132 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 5.5822 Cr -7.9964 Cr 2.3660 Cr -3.8484 Cr 3.0059 Cr 3.0854 Cr -9.4306 Cr -1.4166 Cr 2.3660 Cr 0.0000 Cr -3.5903 Cr
2024-03-31 -15.3965 Cr -10.1144 Cr 25.0031 Cr -25.8618 Cr -0.5078 Cr 0.0789 Cr -10.4653 Cr -2.5551 Cr 30.7606 Cr 0.0000 Cr -0.4499 Cr
2023-03-31 7.4677 Cr -3.4016 Cr -3.7454 Cr 3.2669 Cr 0.3207 Cr 0.5867 Cr -4.2008 Cr 9.4833 Cr 0.7837 Cr 0.0000 Cr -2.5494 Cr
2022-03-31 22.5132 Cr -4.2396 Cr -18.5596 Cr 13.4731 Cr -0.2860 Cr 0.2660 Cr -9.0401 Cr 9.2647 Cr -15.0352 Cr 0.0000 Cr 2.6739 Cr
2021-03-31 16.9850 Cr -11.3565 Cr -6.4170 Cr 10.1443 Cr -0.7885 Cr 0.5520 Cr -6.8407 Cr -0.5532 Cr -0.2539 Cr 0.0000 Cr 11.1298 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 21.84 Cr 12.92 Cr 8.92 Cr 0.4085 2.01 Cr 0.59 Cr 0.57 4.12 Cr 0.0268
2025-09-30 23.52 Cr 13.07 Cr 10.45 Cr 0.4443 2.28 Cr 1.00 Cr 0.97 4.34 Cr 0.0424
2025-06-30 22.64 Cr 9.47 Cr 13.17 Cr 0.5818 1.62 Cr 0.91 Cr 0.89 4.14 Cr 0.0401
2025-03-31 21.20 Cr 13.89 Cr 7.31 Cr 0.3448 1.35 Cr 0.36 Cr 0.35 3.52 Cr 0.0171
2024-12-31 20.46 Cr 8.48 Cr 11.98 Cr 0.5854 1.02 Cr -0.54 Cr -0.53 3.23 Cr -0.0264

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.11 Cr 2.58 Cr 2.69 Cr 38.87 Cr 18.41 Cr 63.68 Cr 92.66 Cr 159.18 Cr 91.22 Cr
2025-06-30 0.00 Cr 0.00 Cr 3.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -67.07 Cr
2025-03-31 3.09 Cr 0.00 Cr 3.09 Cr 41.64 Cr 17.64 Cr 65.11 Cr 94.13 Cr 161.94 Cr 94.88 Cr
2024-12-31 0.00 Cr 0.00 Cr 3.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -67.50 Cr
2024-09-30 0.21 Cr 2.79 Cr 3.00 Cr 41.13 Cr 14.62 Cr 61.29 Cr 95.45 Cr 158.86 Cr 91.36 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.91 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.55 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -0.69 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹841.95 ₹101,036,846,633.00 ₹78,091.00

Key Executives

Chairman, Chief Executive Officer & MD
Anil Kumar Khaitan

Gender: male

Year Born: 1956

GM of Sales Regulated Market
Bipin Nambiar

Gender: male

Year Born: 1975

President of Operation & Marketing
Ishan Khaitan

Gender: male

Year Born: 1987

President of Procurment
Kahaan Khaitan

Gender: male

Year Born: 1991

Chief Financial Officer
Pawan Rathi

Gender: male

Year Born: 1973

Senior Vice President of Marketing
Sanjay Kumar Tiwari

Gender: male

Year Born: 1971

Senior Vice President & Plant Head
Santosh Deshprabhu

Gender: male

Year Born: 1962

Deputy GM of Legal, Company Secretary & Compliance Officer
Satyendu Pattnaik

Gender: male

Year Born: 1974

Chief Strategic Officer
Sarita Khaitan

Gender: female

Year Born: 1957

FAQs about Sunil Healthcare Limited

Who is the CEO of the company?

The CEO is Anil Kumar Khaitan.

What is the current market price of the stock?

The current price is ₹67.00.

What is the 52-week price range?

The range is ₹60.55-88.7.

What is the market capitalization of the company?

The market capitalization is ₹68.71 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 24.08.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Sunil Healthcare Limited (ISIN: INE671C01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹68.71 crores and an average daily volume of 622 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.